Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Knox
Institutions:
University Hospital Southampton NHS Foundation Trust,
University of Southampton
Observed institutions:
University Hospital Southampton NHS Foundation Trust,
University of Southampton
ORCID:
0009-0004-3221-5820
Observed ORCID:
0009-0004-3221-5820
OpenAlex ID:
A5073387972
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
2022
·
Saye H Khoo
, Richard FitzGerald
, et al.
·
The Lancet Infectious Diseases
·
89
PDF
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
2022
·
I’ah Donovan-Banfield
, Rebekah Penrice-Randal
, et al.
·
Nature Communications
·
36
PDF
Seasonality of respiratory viruses and viral co-infection across two winter seasons in the UK.
2024
·
Martha Purcell
, Tommaso Morelli
, et al.
·
European Respiratory Journal
·
3
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection
2026
·
Saye H Khoo
, Richard FitzGerald
, et al.
·
Journal of Antimicrobial Chemotherapy
·
1
291 SynthEtic LEthal Cancer Therapy in mesothelioma (SELECTmeso): a molecularly stratified multi-arm phase II platform trial for patients with relapsed malignant mesothelioma
2026
·
Kayleigh Hill
, Dean Fennell
, et al.
·
Lung Cancer
A platform trial for patients with relapsed malignant mesothelioma
2024
·
Dean Fennell
, Emma Knox
·
http://isrctn.com/
A comparison of clinical and laboratory characteristics in hospitalised adults with and without respiratory viral infection (RVI).
2024
·
Martha Purcell
, Tommaso Morelli
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
7
Citation count:
129
H-index:
3
I10-index:
2
Year
Topic
Type